LXRX
Lexicon Pharmaceuticals, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-05
Figures on this page computed 2026-11-08 12:48 UTC
Last close
1.48USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-03-05
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001062822-26-000050
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-05
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001062822-26-000050
- Reported in
- USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-06
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-06
-101.1%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001062822-26-000050
- Reported in
- USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
-136.2%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001062822-26-000050
- Reported in
- USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
0.58Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001062822-26-000050
- Reported in
- USD
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-06
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Price is the furthest below its sector's middle: 0.13 against 0.38 on the market's range.
- Growth15.7%75 of 100, above its sector
- Returns on capital-46.8%20 of 100, at its sector
- Margins99.5%36 of 100, at its sector
- Price6.0x13 of 100, below its sector
- Safety0.5846 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
What it sells, to whom
lens 8 of 9What it sells
1Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.
1 segments, 0 places and 0 named customers, each as the filer published it.
1 segments, 0 places and 0 named customers, each as the filer published it.
Every figure in this lens
Reportable Segment49,803,00010-K for 2025, filed 2026-03-05
- Source
- filed
- Statement
- segments
- Fiscal year
- 2025
- Accession
- 0001062822-26-000050
- Reported in
- USD